W. Greil

4.3k total citations
105 papers, 2.8k citations indexed

About

W. Greil is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Psychology. According to data from OpenAlex, W. Greil has authored 105 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Psychiatry and Mental health, 16 papers in Pediatrics, Perinatology and Child Health and 16 papers in Clinical Psychology. Recurrent topics in W. Greil's work include Bipolar Disorder and Treatment (54 papers), Electroconvulsive Therapy Studies (27 papers) and Schizophrenia research and treatment (25 papers). W. Greil is often cited by papers focused on Bipolar Disorder and Treatment (54 papers), Electroconvulsive Therapy Studies (27 papers) and Schizophrenia research and treatment (25 papers). W. Greil collaborates with scholars based in Germany, Switzerland and United States. W. Greil's co-authors include Nikolaus Kleindienst, B. Müller‐Oerlinghausen, R. Grohmann, Rolf R. Engel, Jochen Duhm, Bernhard F. Becker, Sermin Toto, Andreas Walther, Adelheid Czernik and Heinrich Sauer and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and FEBS Letters.

In The Last Decade

W. Greil

103 papers receiving 2.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
W. Greil 2.2k 450 447 361 244 105 2.8k
Richard C. Risser 2.6k 1.2× 465 1.0× 321 0.7× 676 1.9× 294 1.2× 48 4.2k
Rasmus Wentzer Licht 3.3k 1.5× 515 1.1× 802 1.8× 608 1.7× 227 0.9× 114 4.2k
K. N. Roy Chengappa 2.4k 1.1× 288 0.6× 577 1.3× 379 1.0× 188 0.8× 98 3.7k
Gary Sachs 3.6k 1.6× 475 1.1× 783 1.8× 711 2.0× 237 1.0× 66 4.1k
Claire O’Donovan 2.0k 0.9× 266 0.6× 426 1.0× 315 0.9× 102 0.4× 37 2.4k
Ronald R. Fieve 1.9k 0.9× 217 0.5× 722 1.6× 427 1.2× 113 0.5× 92 3.1k
Kevin E. Stanford 990 0.4× 194 0.4× 378 0.8× 184 0.5× 125 0.5× 30 2.1k
Martin Brecher 3.3k 1.5× 298 0.7× 489 1.1× 903 2.5× 163 0.7× 74 3.9k
P. C. Baastrup 1.3k 0.6× 197 0.4× 263 0.6× 286 0.8× 99 0.4× 33 1.8k
David G. Daniel 2.7k 1.2× 267 0.6× 678 1.5× 436 1.2× 48 0.2× 91 3.9k

Countries citing papers authored by W. Greil

Since Specialization
Citations

This map shows the geographic impact of W. Greil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Greil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Greil more than expected).

Fields of papers citing papers by W. Greil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Greil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Greil. The network helps show where W. Greil may publish in the future.

Co-authorship network of co-authors of W. Greil

This figure shows the co-authorship network connecting the top 25 collaborators of W. Greil. A scholar is included among the top collaborators of W. Greil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Greil. W. Greil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greil, W., Andreas Erfurth, Gregor Hasler, et al.. (2025). Twenty-four years of prescription patterns in bipolar disorder inpatients with vs without lithium: a pharmacoepidemiological analysis of 8,707 cases in German-speaking countries. International Journal of Bipolar Disorders. 13(1). 3–3. 4 indexed citations
2.
Greil, W., et al.. (2024). Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries. Pharmacopsychiatry. 57(6). 296–303. 4 indexed citations
3.
Seifert, Johanna, Matthias A. Reinhard, Stefan Bleich, et al.. (2024). Psychotropic drug-induced adverse drug reactions in 462,661 psychiatric inpatients in relation to age: results from a German drug surveillance program from 1993–2016. Annals of General Psychiatry. 23(1). 47–47. 4 indexed citations
4.
Grohmann, R., et al.. (2024). Clozapine-associated adverse drug reactions in 38,349 psychiatric inpatients: drug surveillance data from the AMSP project between 1993 and 2016. Journal of Neural Transmission. 131(9). 1117–1134. 1 indexed citations
5.
Greil, W., B. Müller‐Oerlinghausen, Hans H. Stassen, et al.. (2023). Controversies regarding lithium-associated weight gain: case–control study of real-world drug safety data. International Journal of Bipolar Disorders. 11(1). 34–34. 19 indexed citations
6.
Greil, W., Hans H. Stassen, René Bridler, et al.. (2022). Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data. European Archives of Psychiatry and Clinical Neuroscience. 273(1). 65–74. 3 indexed citations
7.
Seifert, Johanna, Matthias A. Reinhard, Rolf R. Engel, et al.. (2021). Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017. Journal of Neural Transmission. 128(6). 827–843. 17 indexed citations
8.
Greil, W., Johanna Seifert, Hans H. Stassen, et al.. (2021). Treatment of depression: Are psychotropic drugs appropriately dosed in women and in the elderly? Dosages of psychotropic drugs by sex and age in routine clinical practice. Human Psychopharmacology Clinical and Experimental. 37(1). e2809–e2809. 8 indexed citations
9.
Seifert, Johanna, Rolf R. Engel, Stefan Bleich, et al.. (2020). Time trends in pharmacological treatment of major depressive disorder: Results from the AMSP Pharmacovigilance Program from 2001–2017. Journal of Affective Disorders. 281. 547–556. 16 indexed citations
10.
Greil, W., Xueqiong Zhang, Hans H. Stassen, et al.. (2018). Cutaneous adverse drug reactions to psychotropic drugs and their risk factors – a case-control study. European Neuropsychopharmacology. 29(1). 111–121. 11 indexed citations
11.
Greil, W., et al.. (2016). Antidepressant Use and Outcomes in Combination with Contraindicated Comedication in a Tertiary Care Hospital. Pharmacoepidemiology and Drug Safety. 1 indexed citations
12.
Bridler, René, et al.. (2015). Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders. European Neuropsychopharmacology. 25(6). 763–772. 66 indexed citations
13.
14.
Tohen, Mauricio, Charles L. Bowden, Smulevich Ab, et al.. (2008). Olanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes. The British Journal of Psychiatry. 192(2). 135–143. 52 indexed citations
15.
Greil, W., et al.. (2006). Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. Journal of Affective Disorders. 99(1-3). 9–17. 51 indexed citations
16.
Kleindienst, Nikolaus & W. Greil. (2004). Are Illness Concepts a Powerful Predictor of Adherence to Prophylactic Treatment in Bipolar Disorder?. The Journal of Clinical Psychiatry. 65(7). 966–974. 38 indexed citations
17.
Grunze, Heinz, J. Walden, Sandra Dittmann, et al.. (2002). Psychopharmakotherapie bipolarer affektiver Erkrankungen. Der Nervenarzt. 73(1). 4–19. 14 indexed citations
18.
Kleindienst, Nikolaus, W. Greil, Bernhard Rüger, & H.‐J. Möller. (1999). The prophylactic efficacy of lithium - transient or persistent?. European Archives of Psychiatry and Clinical Neuroscience. 249(3). 144–149. 16 indexed citations
19.
Ludwig, Wolfgang, Dorothea Huber, Stefanie J. Schmidt, William N. Bender, & W. Greil. (1990). Assessment of complicance-related attitudes in psychiatry. Social Psychiatry and Psychiatric Epidemiology. 25(6). 298–303. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard C. Risser Breakdown of academic impact, for papers by Rasmus Wentzer Licht Breakdown of academic impact, for papers by K. N. Roy Chengappa Breakdown of academic impact, for papers by Gary Sachs Breakdown of academic impact, for papers by Claire O’Donovan Breakdown of academic impact, for papers by Ronald R. Fieve Breakdown of academic impact, for papers by Kevin E. Stanford Breakdown of academic impact, for papers by Martin Brecher Breakdown of academic impact, for papers by P. C. Baastrup Breakdown of academic impact, for papers by David G. Daniel
Rankless by CCL
2026